Continue with FacebookLooking to list your PhD opportunities? Log in here.
anticancer PhD Projects, Programmes & Scholarships
We have 17 anticancer PhD Projects, Programmes & Scholarships
PhD saved successfully
Nanotechnologies for cancer: developing new polymer-drug conjugates for the treatment of a range of cancers
Polymer anticancer-drug conjugates are drug delivery systems in which a low molecular weight anticancer agent is covalently conjugated to a water-soluble polymeric carrier. Read more
Development of peptide hydrogel as an anticancer drug carrier
Growth in nanotechnologies can now be exploited to enable engineering of new drug delivery systems for enhancing the entrapment of drugs in nano-sized structures with tailored physical properties to suit therapeutic need. Read more
New anticancer therapies based on transition metal complexes
Cancer is one of the leading causes of death around the world. Over 50% of cancer tumours are treated with platinum-based metal complexes, like cisplatin and its derivatives. Read more
Graduate Teaching Assistant PhD Scholarship - Sheffield Hallam University: Development of improved body surface area prediction for chemotherapy dose prescription.
Applications are invited for a Graduate Training Assistant (GTA) scholarship in Health and Social Care, commencing 2 October 2023. . Read more
Developing nanoparticles to target neuroendocrine tumour for overcoming resistance to cancer treatment
Many cancer patients having undergone local and systemic treatment eventually develop and die from the progression of distant metastasis associated with the relapse in primary tumour growth. Read more
Last chance to apply
How the interactome defines the biological activity of members of the KDM4A subfamily of histone demethylases
The expression of members of the KDM4A-subfamily of histone demethylases is impaired in various cancers. Different signalling pathways regulate the KDM4A-subfamily interactome, thereby affecting the biological activity of these enzymes. Read more
Last chance to apply
Understanding primary chemotherapy resistance in childhood acute myeloid leukaemia (AML)
Research Group:
The Patrick G Johnston Centre for Cancer Research
Leukamias are the most common childhood cancer and acute myeloid leukaemia (AML) remains a challenging disease. Indeed, 15% of pediatric AML patients suffer failure of induction chemotherapy–in other words, their disease refuses to respond to initial chemotherapeutic attempts. Read more
Last chance to apply
PhD Studentship in the Newcastle University Centre for Cancer - Optimisation of chemotherapy regimens to improve the outcome of children undergoing haematopoietic stem cell transplantation (HSCT) and cancer treatment
Overview. The use of increasingly complex chemotherapy regimes has been transformative for childhood cancer patients, in terms of increasing survival rates. Read more
Translational Medicine: Understanding the mechanism(s) of resistance to EPA to personalise therapy and improve outcome
Advanced colorectal cancer (CRC) is the UK’s second most lethal cancer, with limited treatment options for unresectable metastatic tumours. Read more
Delivery of THC derivatives across the BBB: functionalised polysaccharides nanocarriers
Cannabis sativa, commonly known as marijuana has been found to contain 525 natural components that fall under several chemical classes. Read more
PhD in Chemistry: Medicinal Chemistry of Nucleotide Analogues
Nucleoside analogues (NAs) are an important class of antiviral and anticancer agents commonly used in the therapy of many different viral infections and cancer conditions. Read more
Self Funded PhD Project: Studies on the Design, Synthesis and Biological Evaluation of a Novel Bioactive Indane Scaffold
A wide range of bioactive indane based scaffolds are employed clinically as treatment of many disease states, including inflammatory [1], cancer [2] and neurological conditions [3] and also in the treatment of HIV [4]. Read more
Investigation into the in-vitro lung deposition of liposomal formulations of the dual fixed-dose combination inhaler
Research Group:
Medicines Development and Pharmaceutical Sciences
Asthma and Chronic Obstructive Pulmonary Disease (COPD) are diseases associated with the airflow in the lungs (WHO, 2013). Inhalation is the most effective route of administration for treating asthma and COPD (Labiris and Dolovich, 2003). Read more
Manufacturing the Next Generation of Chemotherapy Drug Delivery Vehicles
Cancer chemotherapy treatments cost the NHS £1.4 Bn each year and cause significant side effects that diminish the quality of life for patients. Read more
Investigation of antagonism of multiple RGD-binding integrins as a therapeutic strategy in advanced head and neck cancer
Research Group:
Institute of Cancer Therapeutics
Background. The integrins are a family of transmembrane receptors which mediate cell-cell and cell-ECM adhesion, and signalling across the cell membrane involved in pathways controlling cell migration, proliferation, differentiation, cell survival and apoptosis. Read more
- 1
- 2